We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.23B
AUM Growth
+$298M
(+4.3%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
2.07%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
1,100
New
151
Increased
415
Reduced
333
Closed
164
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.6M |
| 2 |
Autodesk
ADSK
|
+$38.8M |
| 3 |
Intuit
INTU
|
+$37.1M |
| 4 |
Ecolab
ECL
|
+$35.6M |
| 5 |
Coca-Cola
KO
|
+$35.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$51.9M |
| 2 |
EOG Resources
EOG
|
+$33.8M |
| 3 |
DATA
Tableau Software, Inc.
DATA
|
+$32M |
| 4 |
Microsoft
MSFT
|
+$29.8M |
| 5 |
Ford
F
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 17.68% |
| 3 | Consumer Discretionary | 13.74% |
| 4 | Industrials | 11.53% |
| 5 | Healthcare | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
RingCentral
RNG
$4.05B
| $467K | 0.01% |
4,060
-40,262
| -91% | -$4.64M |
|
|
UCFC
752
DELISTED
United Community Financial Corp
UCFC
| $454K | 0.01% |
47,401
+15,046
| +47% | +$140K |
|
753
Ribbon Communications
RBBN
$354M
| $453K | 0.01% |
92,685
+8,100
| +10% | +$39.6K |
|
754
Delta Air Lines
DAL
$55.9B
| $452K | 0.01% |
7,960
+1,690
| +27% | +$94.7K |
|
|
HZNP
755
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $450K | 0.01% |
18,700
-270,839
| -94% | -$6.87M |
|
|
SAFE
756
Safehold
SAFE
$1.19B
| $446K | 0.01% |
7,380
-5,937
| -45% | -$284K |
|
|
COUP
757
DELISTED
Coupa Software Incorporated
COUP
| $446K | 0.01% |
+3,520
| New | +$378K |
|
758
Commercial Vehicle Group
CVGI
$157M
| $444K | 0.01% |
55,309
-57,700
| -51% | -$450K |
|
|
PSB
759
DELISTED
PS Business Parks, Inc.
PSB
| $443K | 0.01% |
2,630
-2,180
| -45% | -$349K |
|
|
ELGX
760
DELISTED
Endologix Inc
ELGX
| $436K | 0.01% |
60,167
-49,036
| -45% | -$335K |
|
|
EMKR
761
DELISTED
Emcore Corp
EMKR
| $435K | 0.01% |
13,226
+174
| +1% | +$6.47K |
|
|
ECHO
762
EchoStar
ECHO
$25.5B
| $434K | 0.01% |
12,093
-17,326
| -59% | -$577K |
|
763
Andersons Inc
ANDE
$2.65B
| $431K | 0.01% |
15,833
-49,723
| -76% | -$1.48M |
|
764
Digital Turbine
APPS
$1.02B
| $429K | 0.01% |
85,866
-30,754
| -26% | -$124K |
|
765
Nicolet Bankshares
NIC
$3.57B
| $428K | 0.01% |
+6,890
| New | +$417K |
|
|
ZEN
766
DELISTED
ZENDESK INC
ZEN
| $424K | 0.01% |
4,760
-7,230
| -60% | -$621K |
|
767
Texas Capital Bancshares
TCBI
$4.31B
| $423K | 0.01% |
6,890
-24,530
| -78% | -$1.49M |
|
|
BMTC
768
DELISTED
Bryn Mawr Bank Corp
BMTC
| $421K | 0.01% |
11,287
+2,750
| +32% | +$103K |
|
769
Forte Biosciences
FBRX
$1.12B
| $416K | 0.01% |
166
-70
| -30% | -$208K |
|
770
Bassett Furniture
BSET
$169M
| $414K | 0.01% |
27,154
+2,520
| +10% | +$40.4K |
|
771
Fabrinet
FN
$17.1B
| $413K | 0.01% |
8,307
-50
| -0.6% | -$2.64K |
|
772
Prosperity Bancshares
PB
$8.77B
| $406K | 0.01% |
6,140
| – | – |
|
773
Old Second Bancorp
OSBC
$1.24B
| $404K | 0.01% |
31,615
+3,590
| +13% | +$46.2K |
|
|
TGI
774
DELISTED
Triumph Group
TGI
| $400K | 0.01% |
17,480
-393,555
| -96% | -$8.46M |
|
775
Anika Therapeutics
ANIK
$199M
| $397K | 0.01% |
9,768
-8,980
| -48% | -$327K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2019 Portfolio in Review
As of Q2 2019, Jacobs Levy Equity Management held 1,100 positions worth $7.23B, up 4.3% from $6.93B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jacobs Levy Equity Management's Q2 2019 filing shows 151 new, 415 increased, 333 reduced and 164 closed positions. Its largest new stake was Biogen: 175,817 shares worth $41.1M. The largest sale was Allergan plc, an estimated $51.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2019 buy was Biogen: 175,817 shares worth $41.1M.
- Jacobs Levy Equity Management added most to Ecolab in Q2 2019, an estimated $35.6M increase.
- Jacobs Levy Equity Management's biggest Q2 2019 reduction was EOG Resources, cutting an estimated $33.8M.
- Jacobs Levy Equity Management fully exited Allergan plc in Q2 2019, selling an estimated $51.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 15% of its $7.23B portfolio in Q2 2019.
- Jacobs Levy Equity Management opened 151 new positions and closed 164 in Q2 2019.
- Jacobs Levy Equity Management's portfolio value rose 4.3% quarter-over-quarter to $7.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.